MIR 📈 Mirion Technologies - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US60471A1016

MIR: Radiation, Detectors, Dosimeters, Monitors, Imaging, Systems, Software

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia. Web URL: https://www.mirion.com

Additional Sources for MIR Stock

MIR Stock Overview

Market Cap in USD 4,130m
Sector Industrials
Industry Specialty Industrial Machinery
GiC Sub-Industry Industrial Machinery & Supplies & Components
IPO / Inception 2020-08-20

MIR Stock Ratings

Growth 5y 35.0%
Fundamental -14.3%
Dividend -
Rel. Strength Industry 258
Analysts 4.5/5
Fair Price Momentum 17.74 USD
Fair Price DCF 6.31 USD

MIR Dividends

No Dividends Paid

MIR Growth Ratios

Growth Correlation 3m 97.4%
Growth Correlation 12m 68.9%
Growth Correlation 5y -4.1%
CAGR 5y 14.44%
CAGR/Mean DD 5y 0.42
Sharpe Ratio 12m 1.61
Alpha 41.71
Beta 1.22
Volatility 42.31%
Current Volume 3837k
Average Volume 20d 2416k
What is the price of MIR stocks?
As of December 22, 2024, the stock is trading at USD 17.89 with a total of 3,836,965 shares traded.
Over the past week, the price has changed by -0.78%, over one month by +11.33%, over three months by +67.51% and over the past year by +76.08%.
Is Mirion Technologies a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Mirion Technologies is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -14.28 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MIR as of December 2024 is 17.74. This means that MIR is currently overvalued and has a potential downside of -0.84%.
Is MIR a buy, sell or hold?
Mirion Technologies has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy MIR.
  • Strong Buy: 2
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for MIR stock price target?
According to ValueRays Forecast Model, MIR Mirion Technologies will be worth about 19.7 in December 2025. The stock is currently trading at 17.89. This means that the stock has a potential upside of +10.06%.
Issuer Forecast Upside
Wallstreet Target Price 18.5 3.4%
Analysts Target Price 10.7 -40.4%
ValueRay Target Price 19.7 10.1%